Selected research
Industry Research
HER2 Antibody Industry Research Report 2026
Market perspective
The global HER2 Antibody market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the HER2 Antibody market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the HER2 Antibody market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the HER2 Antibody market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of HER2 Antibody include Novartis AG, Pfizer, InvivoGen, Genentech Inc, Celltrion, Bio-Techne, Biocon Limited and Abnova Corporation, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global HER2 Antibody market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to HER2 Antibody.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
HER2 Antibody Market by Company
Novartis AG
Pfizer
InvivoGen
Genentech Inc
Celltrion
Bio-Techne
Biocon Limited
Abnova Corporation
HER2 Antibody Segment by Type
Ado-trastuzumab Emtansine
Lapatinib
Pertuzumab
Trastuzumab
Everolimus
HER2 Antibody Segment by Application
Hospital
Medical Center
HER2 Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HER2 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HER2 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HER2 Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of HER2 Antibody companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ado-trastuzumab Emtansine
- Lapatinib
- Pertuzumab
- Trastuzumab
- Everolimus
Applications
- Hospital
- Medical Center
Companies covered
- Novartis AG
- Pfizer
- InvivoGen
- Genentech Inc
- Celltrion
- Bio-Techne
- Biocon Limited
- Abnova Corporation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 HER2 Antibody by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Ado-trastuzumab Emtansine
- 2.2.3 Lapatinib
- 2.2.4 Pertuzumab
- 2.2.5 Trastuzumab
- 2.2.6 Everolimus
- 2.3 HER2 Antibody by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Medical Center
- 2.4 Assumptions and Limitations
3 HER2 Antibody Breakdown Data by Type
- 3.1 Global HER2 Antibody Historic Market Size by Type (2021-2026)
- 3.2 Global HER2 Antibody Forecasted Market Size by Type (2027-2032)
4 HER2 Antibody Breakdown Data by Application
- 4.1 Global HER2 Antibody Historic Market Size by Application (2021-2026)
- 4.2 Global HER2 Antibody Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global HER2 Antibody Market Perspective (2021-2032)
- 5.2 Global HER2 Antibody Growth Trends by Region
- 5.2.1 Global HER2 Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 HER2 Antibody Historic Market Size by Region (2021-2026)
- 5.2.3 HER2 Antibody Forecasted Market Size by Region (2027-2032)
- 5.3 HER2 Antibody Market Dynamics
- 5.3.1 HER2 Antibody Industry Trends
- 5.3.2 HER2 Antibody Market Drivers
- 5.3.3 HER2 Antibody Market Challenges
- 5.3.4 HER2 Antibody Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top HER2 Antibody Players by Revenue
- 6.1.1 Global Top HER2 Antibody Players by Revenue (2021-2026)
- 6.1.2 Global HER2 Antibody Revenue Market Share by Players (2021-2026)
- 6.2 Global HER2 Antibody Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of HER2 Antibody Head Office and Area Served
- 6.4 Global HER2 Antibody Players, Product Type & Application
- 6.5 Global HER2 Antibody Manufacturers Established Date
- 6.6 Global HER2 Antibody Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America HER2 Antibody Market Size (2021-2032)
- 7.2 North America HER2 Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America HER2 Antibody Market Size by Country (2021-2026)
- 7.4 North America HER2 Antibody Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe HER2 Antibody Market Size (2021-2032)
- 8.2 Europe HER2 Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe HER2 Antibody Market Size by Country (2021-2026)
- 8.4 Europe HER2 Antibody Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific HER2 Antibody Market Size (2021-2032)
- 9.2 Asia-Pacific HER2 Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific HER2 Antibody Market Size by Country (2021-2026)
- 9.4 Asia-Pacific HER2 Antibody Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America HER2 Antibody Market Size (2021-2032)
- 10.2 South America HER2 Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America HER2 Antibody Market Size by Country (2021-2026)
- 10.4 South America HER2 Antibody Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa HER2 Antibody Market Size (2021-2032)
- 11.2 Middle East & Africa HER2 Antibody Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa HER2 Antibody Market Size by Country (2021-2026)
- 11.4 Middle East & Africa HER2 Antibody Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Novartis AG
- 12.1.1 Novartis AG Company Information
- 12.1.2 Novartis AG Business Overview
- 12.1.3 Novartis AG Revenue in HER2 Antibody Business (2021-2026)
- 12.1.4 Novartis AG HER2 Antibody Product Portfolio
- 12.1.5 Novartis AG Recent Developments
- 12.2 Pfizer
- 12.2.1 Pfizer Company Information
- 12.2.2 Pfizer Business Overview
- 12.2.3 Pfizer Revenue in HER2 Antibody Business (2021-2026)
- 12.2.4 Pfizer HER2 Antibody Product Portfolio
- 12.2.5 Pfizer Recent Developments
- 12.3 InvivoGen
- 12.3.1 InvivoGen Company Information
- 12.3.2 InvivoGen Business Overview
- 12.3.3 InvivoGen Revenue in HER2 Antibody Business (2021-2026)
- 12.3.4 InvivoGen HER2 Antibody Product Portfolio
- 12.3.5 InvivoGen Recent Developments
- 12.4 Genentech Inc
- 12.4.1 Genentech Inc Company Information
- 12.4.2 Genentech Inc Business Overview
- 12.4.3 Genentech Inc Revenue in HER2 Antibody Business (2021-2026)
- 12.4.4 Genentech Inc HER2 Antibody Product Portfolio
- 12.4.5 Genentech Inc Recent Developments
- 12.5 Celltrion
- 12.5.1 Celltrion Company Information
- 12.5.2 Celltrion Business Overview
- 12.5.3 Celltrion Revenue in HER2 Antibody Business (2021-2026)
- 12.5.4 Celltrion HER2 Antibody Product Portfolio
- 12.5.5 Celltrion Recent Developments
- 12.6 Bio-Techne
- 12.6.1 Bio-Techne Company Information
- 12.6.2 Bio-Techne Business Overview
- 12.6.3 Bio-Techne Revenue in HER2 Antibody Business (2021-2026)
- 12.6.4 Bio-Techne HER2 Antibody Product Portfolio
- 12.6.5 Bio-Techne Recent Developments
- 12.7 Biocon Limited
- 12.7.1 Biocon Limited Company Information
- 12.7.2 Biocon Limited Business Overview
- 12.7.3 Biocon Limited Revenue in HER2 Antibody Business (2021-2026)
- 12.7.4 Biocon Limited HER2 Antibody Product Portfolio
- 12.7.5 Biocon Limited Recent Developments
- 12.8 Abnova Corporation
- 12.8.1 Abnova Corporation Company Information
- 12.8.2 Abnova Corporation Business Overview
- 12.8.3 Abnova Corporation Revenue in HER2 Antibody Business (2021-2026)
- 12.8.4 Abnova Corporation HER2 Antibody Product Portfolio
- 12.8.5 Abnova Corporation Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst